Cationic Nanomicelles for Delivery of Plasmids Encoding Interleukin-4 and Interleukin-10 for Prevention of Autoimmune Diabetes in Mice

[1]  Joel A. Cohen,et al.  Acid-degradable cationic dextran particles for the delivery of siRNA therapeutics. , 2011, Bioconjugate chemistry.

[2]  J. Rosenecker,et al.  Expression of therapeutic proteins after delivery of chemically modified mRNA in mice , 2011, Nature Biotechnology.

[3]  N. Düzgüneş,et al.  Gene delivery by lipoplexes and polyplexes. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  T. Oh,et al.  Delivery of Factor VIII Gene into Skeletal Muscle Cells Using Lentiviral Vector , 2009, Yonsei medical journal.

[5]  A. Sapin,et al.  Optimization of a New Non-viral Vector for Transfection: Eudragit Nanoparticles for the Delivery of a DNA Plasmid , 2009, Technology in cancer research & treatment.

[6]  Sangkyun Lee,et al.  TGFβ Plasmid Construction and Delivery for the Prevention of Type 1 Diabetes , 2008, Annals of the New York Academy of Sciences.

[7]  R. Tisch,et al.  Immunotherapy of type 1 diabetes , 2008, Archivum Immunologiae et Therapiae Experimentalis.

[8]  B. Pitard,et al.  Therapy of anemia in kidney failure, using plasmid encoding erythropoietin. , 2008, Human gene therapy.

[9]  Kenneth K. Wu,et al.  Streptozotocin‐Induced Diabetic Models in Mice and Rats , 2008, Current protocols in pharmacology.

[10]  Minhyung Lee,et al.  Interleukin‐10 Plasmid Construction and Delivery for the Prevention of Type 1 Diabetes , 2005, Annals of the New York Academy of Sciences.

[11]  K. Eguchi,et al.  Prevention of type 1 diabetes: from the view point of β cell damage , 2004 .

[12]  O. Podhajcer,et al.  Gene therapy for autoimmune diseases: quo vadis? , 2004, Nature Reviews Immunology.

[13]  R. Schmidt,et al.  Non-obese diabetic mice rapidly develop dramatic sympathetic neuritic dystrophy: a new experimental model of diabetic autonomic neuropathy. , 2003, The American journal of pathology.

[14]  S. W. Kim,et al.  Prevention of autoimmune insulitis by delivery of a chimeric plasmid encoding interleukin-4 and interleukin-10. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[15]  K. Roy,et al.  Gene delivery with in-situ crosslinking polymer networks generates long-term systemic protein expression. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[16]  G. Eisenbarth,et al.  Immunologic endocrine disorders. , 2003, The Journal of allergy and clinical immunology.

[17]  T. Niidome,et al.  Gene Therapy Progress and Prospects: Nonviral vectors , 2002, Gene Therapy.

[18]  S. W. Kim,et al.  Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  J. Behr,et al.  Dimerizable cationic detergents with a low cmc condense plasmid DNA into nanometric particles and transfect cells in culture. , 2001, Journal of the American Chemical Society.

[20]  S. Carotta,et al.  Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo , 2001, The journal of gene medicine.

[21]  S. W. Kim,et al.  Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice , 2000, Gene Therapy.

[22]  M. Cameron,et al.  Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer , 2000, Gene Therapy.

[23]  M. Cameron,et al.  Biolistic-mediated interleukin 4 gene transfer prevents the onset of type 1 diabetes. , 2000, Human gene therapy.

[24]  G. Prud’homme,et al.  Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion protein , 1999, Gene Therapy.

[25]  C. Piccirillo,et al.  TGF-β1 Somatic Gene Therapy Prevents Autoimmune Disease in Nonobese Diabetic Mice , 1998, The Journal of Immunology.

[26]  J. Miyazaki,et al.  Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice. , 1998, Human gene therapy.

[27]  J. Leiden,et al.  Recent advances in skeletal-muscle-based gene therapy. , 1998, Current opinion in genetics & development.

[28]  K. Leong,et al.  DNA-polycation nanospheres as non-viral gene delivery vehicles. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[29]  R. Strieter,et al.  IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. , 1997, Journal of immunology.

[30]  Roland L. Dunbrack,et al.  The Proton Sponge: a Trick to Enter Cells the Viruses Did Not Exploit , 1997, CHIMIA.

[31]  H. Kolb,et al.  Primary nonfunction of islet grafts in autoimmune diabetic nonobese diabetic mice is prevented by treatment with interleukin-4 and interleukin-10. , 1996, Transplantation.

[32]  H. Blau,et al.  Muscle-mediated gene therapy. , 1995, The New England journal of medicine.

[33]  Jagdish Singh,et al.  Effect of acyl chain length and unsaturation on physicochemical properties and transfection efficiency of N-acyl-substituted low-molecular-weight chitosan. , 2012, Journal of pharmaceutical sciences.

[34]  A. Biris,et al.  Characterization of plasmid DNA location within chitosan/PLGA/pDNA nanoparticle complexes designed for gene delivery , 2011 .

[35]  A. Domb,et al.  Synthesis of cationic polysaccharides and use for in vitro transfection. , 2011, Cold Spring Harbor protocols.

[36]  Jagdish Singh,et al.  Poly (lactide-co-glycolide)-Polymethacrylate Nanoparticles for Intramuscular Delivery of Plasmid Encoding Interleukin-10 to Prevent Autoimmune Diabetes in Mice , 2008, Pharmaceutical Research.

[37]  J. Wolff,et al.  The mechanism of naked DNA uptake and expression. , 2005, Advances in genetics.

[38]  K. Eguchi,et al.  Prevention of type 1 diabetes: from the view point of beta cell damage. , 2004, Diabetes research and clinical practice.

[39]  S. W. Kim,et al.  Biodegradable Polyester, Poly[α-(4-Aminobutyl)-l-Glycolic Acid], as a Non-Toxic Gene Carrier , 2004, Pharmaceutical Research.

[40]  Y. Suh,et al.  Intraperitoneal gene delivery mediated by a novel cationic liposome in a peritoneal disseminated ovarian cancer model , 2002, Gene Therapy.

[41]  Y. Lim,et al.  Biodegradable polyester, poly[alpha-(4-aminobutyl)-L-glycolic acid], as a non-toxic gene carrier. , 2000, Pharmaceutical research.

[42]  C. Piccirillo,et al.  TGF-beta1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice. , 1998, Journal of immunology.

[43]  Peter Belfer.  Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein , 1996 .